EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Can garlic‐intake reduce the risk of cancer? A systematic review of randomised controlled trials

Edzard Ernst, Paul Posadzki

Focus on Alternative and Complementary Therapies · 2012

DOI: 10.1111/fct.12000 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Many authors have explored the intriguing possibility that the regular intake of Allium sativum (garlic) might reduce cancer risk. Most of this evidence is based on epidemiological data which, by its very nature, may not be fully convincing in establishing causality. Objective To critically evaluate the evidence of effectiveness of garlic extract for reducing cancer risk. Methods Five electronic databases and the authors' own departmental files were searched for relevant studies. Randomised controlled trials ( RCT s) were included if they tested the effectiveness of garlic extracts or garlic compounds on cancer risk or related variables. The quality of included trials was determined using the J adad score. Results Four eligible RCT s were identified. The quality of studies was mixed. The findings from these trials were not uniformly positive. Conclusions Evidence from RCT s lends little support to the notion that garlic reduces the risk of cancer.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →